SlideShare a Scribd company logo
Dermal irritation study
according to
OECD(404) guidelines
PRESENTED TO
-
Dr. Badruddeen
PRESENTED BY -
MO.Shahanawaz
M.Pharm 1st year 2nd sem.
(Pharmacological and Toxicological
Screening)
HANDLING AND
RESTRAINT
Rabbits are
especially
susceptible to
the effects of
stress and
should always
be
approached
in a calm and
confident
manner.
The handler is
restraining the
rabbit firmly by
the scruff with
the other hand
ready to support
the animal’s
hindquarters.
There is no one
correct method of
handling or
restraining
animals, but the
general principle
is that it should
not cause pain or
discomfort to the
animal. It should
also be
comfortable for
the handler.
The methods
shown in the
species-specific
sections are
recommended,
although some
people may feel
more comfortable
using slightly
different ways to
restrain the
animals, which is
also acceptable.
INTRODUCTION
• DERMAL IRRITATION is the production of reversible damage of the skin following
the application of a test chemical for up to 4 hours.
• Dermal corrosion is the production of irreversible damage of the skin; namely, visible
necrosis through the epidermis and into the dermis, following the application of a test
chemical for up to four hours.
• Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of
observation at 14 days, by discolouration due to blanching of the skin, complete areas
of alopecia, and scars.
• OECD Guidelines for Testing of Chemicals are periodically reviewed to ensure that
they reflect the best available science.
• In the review of this Guideline, special attention was given to possible improvements in
relation to animal welfare concerns and to the evaluation of all existing information on
the test chemical in order to avoid unnecessary testing in laboratory animals.
PRINCIPLE
• The test chemical to be tested is applied in a single dose to the skin of an
experimental animal; untreated skin areas of the test animal serve as the
control.
• The degree of irritation/corrosion is read and scored at specified intervals
and is further described in order to provide a complete evaluation of the
effects.
• The duration of the study should be sufficient to evaluate the reversibility or
irreversibility of the effects observed.
• Animals showing continuing signs of severe distress and/or pain at any stage
of the test should be humanely killed, and the test chemical assessed
accordingly.
• Criteria for making the decision to humanely kill moribund and severely
suffering animals are the subject of a separate Guidance Document.
PREPARATION FOR THE IN VIVO TEST
SELECTION OF ANIMAL SPECIES-
• The albino rabbit is the preferable laboratory animal and healthy young adult rabbits
are used.
• A rationale for using other species should be provided.
PREPARATION OF THE ANIMALS-
• Approximately 24 hours before the test, fur should be removed by closely clipping the
dorsal area of the trunk of the animals.
• Care should be taken to avoid abrading the skin, and only animals with healthy, intact
skin should be used.
• Some strains of rabbit have dense patches of hair that are more prominent at certain
times of the year. Such areas of dense hair growth should not be used as test sites.
HOUSING AND FEEDING CONDITIONS -
• Animals should be individually housed.
• Rabbit at least 12 weeks old and body weight 1.5 kg-3.0 kg.
• The temperature should be 200C (± 30C) for rabbits.
• Relative humidity should be at least 30% and preferably not exceed 70%, other
than during room cleaning; the aim should be 50-60%.
• Lighting should be 12 hours light, 12 hours dark.
• For feeding, conventional laboratory diets may be used with an unrestricted
supply of drinking water.
TEST PROCEDURE
APPLICATION OF THE TEST CHEMICAL
• The test chemical should be applied to a dorsal/flank region (approximately 6 cm2) of
skin and covered with a gauze patch, which is held in place with non- irritating tape.
• In cases in which direct application is not possible (e.g., liquids or some pastes), the
test chemical should first be applied to the gauze patch, which is then applied to the
skin.
• The patch should be loosely held in contact with the skin by means of a suitable semi-
occlusive dressing for the duration of the exposure period.
• If the test chemical is applied to the patch, it should be attached to the skin in such a
manner that there is good contact and uniform distribution of the test chemical on the
skin.
• Access by the animal to the patch and ingestion or inhalation of the test chemical
should be prevented.
• Liquid test chemicals are generally used undiluted. • When testing solids (which may
be pulverised, if considered necessary), the test chemical should be moistened with
the smallest amount of water (or, where necessary, of another suitable vehicle)
sufficient to ensure good skin contact.
• When vehicles other than water are used, the potential influence of the vehicle on
irritation of the skin by the test chemical should be minimal, if any.
• At the end of the exposure period, which is normally 4 hours, residual test
chemical should be removed, where practicable, using water or an appropriate solvent
without altering the existing response or the integrity of the epidermis.
DOSE LEVEL
• A dose of 0.5 mL of liquid or 0.5 g of solid or paste is applied to the test site.
INITIAL TEST (USING ONE ANIMAL)
 When a test chemical has been judged to be corrosive, irritant or non-
classified on the basis of a weight of evidence analyses or of previous in
vitro testing, further in vivo testing is normally not necessary.
 However, in the cases where additional data are felt warranted, the in vivo
test is performed initially using one animal and applying the following
approach.
 Up to three test patches are applied sequentially to the animal.
 The first patch is removed after three minutes.
 If no serious skin reaction is observed, a second patch is applied at a
different site and removed after one hour.
 If the observations at this stage indicate that exposure can humanely be
allowed to extend to four hours, a third patch is applied and removed after
four hours, and the response is graded.
 If a corrosive effect is observed after any of the three sequential exposures,
the test is immediately terminated.
 If a corrosive effect is not observed after the last patch is removed, the
animal is observed for 14 days, unless corrosion develops at an earlier time
point.
 In those cases, in which the test chemical is not expected to produce
corrosion but may be irritating, a single patch should be applied to one animal
for four hours.
CONFIRMATORY TEST (WITH ADDITIONAL ANIMALS)
 If a corrosive effect is not observed in the initial test, the irritant or negative
response should be confirmed using up to two additional animals, each with one patch,
for an exposure period of four hours.
 If an irritant effect is observed in the initial test, the confirmatory test may be
conducted in a sequential manner, or by exposing two additional animals simultaneously.
 In the exceptional case, in which the initial test is not conducted, two or three
animals may be treated with a single patch, which is removed after four hours.
 When two animals are used, if both exhibit the same response, no further testing is
needed. Otherwise, the third animal is also tested.
 Equivocal responses may need to be evaluated using additional animals.
OBSERVATION PERIOD
 The duration of the observation period should be sufficient to evaluate fully
the reversibility of the effects observed.
 The experiment should be terminated at any time that the animal shows continuing
signs of severe pain or distress.
 To determine the reversibility of effects, the animals should be observed up to 14
days after removal of the patches.
 If reversibility is seen before 14 days, the experiment should be terminated
at that time.
CLINICAL OBSERVATIONS AND GRADING OF SKIN
REACTIONS
 All animals should be examined for signs of erythema and oedema, and the
responses scored at 60 minutes, and then at 24, 48 and 72 hours after patch
removal.
 For the initial test in one animal, the test site is also examined immediately after
the patch has been removed.
 Dermal reactions are graded and recorded according to the grades in the Table
below.
 If there is damage to skin which cannot be identified as irritation or corrosion at
72 hours, observations may be needed until day 14 to determine the reversibility
of the effects.
 In addition to the observation of irritation, all local toxic effects, such as
defatting of the skin, and any systemic adverse effects (e.g., effects on clinical
signs of toxicity and body weight), should be fully described and recorded.
 Histopathological examination should be considered to clarify equivocal
responses.
THANK YOU

More Related Content

What's hot

Acute toxicity studies-425
Acute toxicity studies-425Acute toxicity studies-425
Acute toxicity studies-425
jeshicabulsara
 
Acute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelinesAcute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelines
madhvi Chaubey
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
Shivanshu Bajaj
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
SONALPANDE5
 
Documentation clinical trial
Documentation clinical trialDocumentation clinical trial
Documentation clinical trial
ankit sharma
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
helasri gummadi
 
Acute inhalational toxicity studies.pptx
 Acute inhalational toxicity studies.pptx Acute inhalational toxicity studies.pptx
Acute inhalational toxicity studies.pptx
Tanuj Silori
 
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspectiveIND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspective
AYESHA NAZEER
 
Dose selection
Dose selectionDose selection
Dose selection
pp_shivgunde
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
Dr Ajay Mandal
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
HimikaRathi
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
Kashikant Yadav
 
Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies
Dinesh Gangoda
 
REPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIESREPRODUCTIVE TOXICITY STUDIES
Importance of guidelines in regulatory toxicity testing
Importance of guidelines in regulatory toxicity testingImportance of guidelines in regulatory toxicity testing
Importance of guidelines in regulatory toxicity testing
Chander K Negi
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Shivam Diwaker
 
Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)
suhaspatil114
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
ragini Dani
 
Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on Toxicokinetics
Deepak Kumar
 

What's hot (20)

Acute toxicity studies-425
Acute toxicity studies-425Acute toxicity studies-425
Acute toxicity studies-425
 
Acute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelinesAcute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelines
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
Invivo Carcinogenecity Studies
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
 
Documentation clinical trial
Documentation clinical trialDocumentation clinical trial
Documentation clinical trial
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
 
Acute inhalational toxicity studies.pptx
 Acute inhalational toxicity studies.pptx Acute inhalational toxicity studies.pptx
Acute inhalational toxicity studies.pptx
 
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspectiveIND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspective
 
Dose selection
Dose selectionDose selection
Dose selection
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies
 
REPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIESREPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIES
 
Importance of guidelines in regulatory toxicity testing
Importance of guidelines in regulatory toxicity testingImportance of guidelines in regulatory toxicity testing
Importance of guidelines in regulatory toxicity testing
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
 
Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
 
Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on Toxicokinetics
 

Similar to DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES

acute dermal irritation .pptx
acute dermal irritation .pptxacute dermal irritation .pptx
acute dermal irritation .pptx
jatinsaini78
 
dermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptxdermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptx
yashvikhankar1
 
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptxDermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Ashish Gadage
 
dermal toxicity.pptx
dermal toxicity.pptxdermal toxicity.pptx
dermal toxicity.pptx
VaishnaviPatel76
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Ch. Bhargava krishna
 
skin sensitisation test
 skin sensitisation test skin sensitisation test
skin sensitisation test
mominasran
 
Acute Eye Irritation\Corrosion toxicology studies
Acute Eye Irritation\Corrosion  toxicology studiesAcute Eye Irritation\Corrosion  toxicology studies
Acute Eye Irritation\Corrosion toxicology studies
Himanshu Yadav
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
Himanshu Yadav
 
Skin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptxSkin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptx
NikitaBankoti2
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Shubhu20
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
Priya818982
 
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptxAcute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Dublinmatcher
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405
Dr Ajay Mandal
 
Acute eye irritation oecd
Acute eye irritation oecdAcute eye irritation oecd
Acute eye irritation oecd
DRx Priya Shukla
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
KhushbooThakur15
 
Expt. 11 Determination of acute eye irritation corrosion of a test substance
Expt. 11 Determination of acute eye irritation  corrosion of a test substanceExpt. 11 Determination of acute eye irritation  corrosion of a test substance
Expt. 11 Determination of acute eye irritation corrosion of a test substance
VISHALJADHAV100
 
Acute Toxicity by OECD Guidelines
Acute Toxicity by OECD Guidelines Acute Toxicity by OECD Guidelines
Acute Toxicity by OECD Guidelines
Sagar Dalvi
 
Inhalation Toxicity Studies- OECD guidelines
 Inhalation Toxicity Studies- OECD guidelines Inhalation Toxicity Studies- OECD guidelines
Inhalation Toxicity Studies- OECD guidelines
Cerin Philip
 
OECD guidelines-Organisation for Economic Co-operation and Development guidel...
OECD guidelines-Organisation for Economic Co-operation and Development guidel...OECD guidelines-Organisation for Economic Co-operation and Development guidel...
OECD guidelines-Organisation for Economic Co-operation and Development guidel...
Hemadharshini Senthill
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
drkamalsahil
 

Similar to DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES (20)

acute dermal irritation .pptx
acute dermal irritation .pptxacute dermal irritation .pptx
acute dermal irritation .pptx
 
dermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptxdermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptx
 
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptxDermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
 
dermal toxicity.pptx
dermal toxicity.pptxdermal toxicity.pptx
dermal toxicity.pptx
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
 
skin sensitisation test
 skin sensitisation test skin sensitisation test
skin sensitisation test
 
Acute Eye Irritation\Corrosion toxicology studies
Acute Eye Irritation\Corrosion  toxicology studiesAcute Eye Irritation\Corrosion  toxicology studies
Acute Eye Irritation\Corrosion toxicology studies
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
 
Skin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptxSkin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptx
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
 
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptxAcute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405
 
Acute eye irritation oecd
Acute eye irritation oecdAcute eye irritation oecd
Acute eye irritation oecd
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
 
Expt. 11 Determination of acute eye irritation corrosion of a test substance
Expt. 11 Determination of acute eye irritation  corrosion of a test substanceExpt. 11 Determination of acute eye irritation  corrosion of a test substance
Expt. 11 Determination of acute eye irritation corrosion of a test substance
 
Acute Toxicity by OECD Guidelines
Acute Toxicity by OECD Guidelines Acute Toxicity by OECD Guidelines
Acute Toxicity by OECD Guidelines
 
Inhalation Toxicity Studies- OECD guidelines
 Inhalation Toxicity Studies- OECD guidelines Inhalation Toxicity Studies- OECD guidelines
Inhalation Toxicity Studies- OECD guidelines
 
OECD guidelines-Organisation for Economic Co-operation and Development guidel...
OECD guidelines-Organisation for Economic Co-operation and Development guidel...OECD guidelines-Organisation for Economic Co-operation and Development guidel...
OECD guidelines-Organisation for Economic Co-operation and Development guidel...
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
 

More from MO.SHAHANAWAZ

MASS SPECTROSCOPY.pptx
MASS SPECTROSCOPY.pptxMASS SPECTROSCOPY.pptx
MASS SPECTROSCOPY.pptx
MO.SHAHANAWAZ
 
Methods of Asymmetric Synthesis using chiral pool 2.pptx
Methods of Asymmetric Synthesis using chiral pool 2.pptxMethods of Asymmetric Synthesis using chiral pool 2.pptx
Methods of Asymmetric Synthesis using chiral pool 2.pptx
MO.SHAHANAWAZ
 
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxPREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
MO.SHAHANAWAZ
 
Gass Chromatography Atomic Absorption spectroscopy(GC-AAS)
Gass Chromatography Atomic Absorption spectroscopy(GC-AAS)Gass Chromatography Atomic Absorption spectroscopy(GC-AAS)
Gass Chromatography Atomic Absorption spectroscopy(GC-AAS)
MO.SHAHANAWAZ
 
HOMOLOGY MODELLING.pptx
HOMOLOGY MODELLING.pptxHOMOLOGY MODELLING.pptx
HOMOLOGY MODELLING.pptx
MO.SHAHANAWAZ
 
PROCESS FOR TECHNICAL NITRATION.pptx
PROCESS FOR TECHNICAL NITRATION.pptxPROCESS FOR TECHNICAL NITRATION.pptx
PROCESS FOR TECHNICAL NITRATION.pptx
MO.SHAHANAWAZ
 
FRAGMENT-BASED DRUG DISCOVERY.pptx
FRAGMENT-BASED DRUG DISCOVERY.pptxFRAGMENT-BASED DRUG DISCOVERY.pptx
FRAGMENT-BASED DRUG DISCOVERY.pptx
MO.SHAHANAWAZ
 
in silico drug design and virtual screening technique
 in silico drug design and virtual screening technique in silico drug design and virtual screening technique
in silico drug design and virtual screening technique
MO.SHAHANAWAZ
 
Evaporation
EvaporationEvaporation
Evaporation
MO.SHAHANAWAZ
 
12 PRINCIPLES OF GREEN CHEMISTRY.pptx
12 PRINCIPLES OF GREEN CHEMISTRY.pptx12 PRINCIPLES OF GREEN CHEMISTRY.pptx
12 PRINCIPLES OF GREEN CHEMISTRY.pptx
MO.SHAHANAWAZ
 
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptxMOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MO.SHAHANAWAZ
 
PRESENTATION ON STEREOCHEMISTRY MO SHAHANAWAZ.pptx
PRESENTATION ON STEREOCHEMISTRY MO SHAHANAWAZ.pptxPRESENTATION ON STEREOCHEMISTRY MO SHAHANAWAZ.pptx
PRESENTATION ON STEREOCHEMISTRY MO SHAHANAWAZ.pptx
MO.SHAHANAWAZ
 

More from MO.SHAHANAWAZ (12)

MASS SPECTROSCOPY.pptx
MASS SPECTROSCOPY.pptxMASS SPECTROSCOPY.pptx
MASS SPECTROSCOPY.pptx
 
Methods of Asymmetric Synthesis using chiral pool 2.pptx
Methods of Asymmetric Synthesis using chiral pool 2.pptxMethods of Asymmetric Synthesis using chiral pool 2.pptx
Methods of Asymmetric Synthesis using chiral pool 2.pptx
 
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxPREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
 
Gass Chromatography Atomic Absorption spectroscopy(GC-AAS)
Gass Chromatography Atomic Absorption spectroscopy(GC-AAS)Gass Chromatography Atomic Absorption spectroscopy(GC-AAS)
Gass Chromatography Atomic Absorption spectroscopy(GC-AAS)
 
HOMOLOGY MODELLING.pptx
HOMOLOGY MODELLING.pptxHOMOLOGY MODELLING.pptx
HOMOLOGY MODELLING.pptx
 
PROCESS FOR TECHNICAL NITRATION.pptx
PROCESS FOR TECHNICAL NITRATION.pptxPROCESS FOR TECHNICAL NITRATION.pptx
PROCESS FOR TECHNICAL NITRATION.pptx
 
FRAGMENT-BASED DRUG DISCOVERY.pptx
FRAGMENT-BASED DRUG DISCOVERY.pptxFRAGMENT-BASED DRUG DISCOVERY.pptx
FRAGMENT-BASED DRUG DISCOVERY.pptx
 
in silico drug design and virtual screening technique
 in silico drug design and virtual screening technique in silico drug design and virtual screening technique
in silico drug design and virtual screening technique
 
Evaporation
EvaporationEvaporation
Evaporation
 
12 PRINCIPLES OF GREEN CHEMISTRY.pptx
12 PRINCIPLES OF GREEN CHEMISTRY.pptx12 PRINCIPLES OF GREEN CHEMISTRY.pptx
12 PRINCIPLES OF GREEN CHEMISTRY.pptx
 
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptxMOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
 
PRESENTATION ON STEREOCHEMISTRY MO SHAHANAWAZ.pptx
PRESENTATION ON STEREOCHEMISTRY MO SHAHANAWAZ.pptxPRESENTATION ON STEREOCHEMISTRY MO SHAHANAWAZ.pptx
PRESENTATION ON STEREOCHEMISTRY MO SHAHANAWAZ.pptx
 

Recently uploaded

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 

Recently uploaded (20)

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 

DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES

  • 1. Dermal irritation study according to OECD(404) guidelines PRESENTED TO - Dr. Badruddeen PRESENTED BY - MO.Shahanawaz M.Pharm 1st year 2nd sem. (Pharmacological and Toxicological Screening)
  • 2. HANDLING AND RESTRAINT Rabbits are especially susceptible to the effects of stress and should always be approached in a calm and confident manner. The handler is restraining the rabbit firmly by the scruff with the other hand ready to support the animal’s hindquarters. There is no one correct method of handling or restraining animals, but the general principle is that it should not cause pain or discomfort to the animal. It should also be comfortable for the handler. The methods shown in the species-specific sections are recommended, although some people may feel more comfortable using slightly different ways to restrain the animals, which is also acceptable.
  • 3. INTRODUCTION • DERMAL IRRITATION is the production of reversible damage of the skin following the application of a test chemical for up to 4 hours. • Dermal corrosion is the production of irreversible damage of the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test chemical for up to four hours. • Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. • OECD Guidelines for Testing of Chemicals are periodically reviewed to ensure that they reflect the best available science. • In the review of this Guideline, special attention was given to possible improvements in relation to animal welfare concerns and to the evaluation of all existing information on the test chemical in order to avoid unnecessary testing in laboratory animals.
  • 4. PRINCIPLE • The test chemical to be tested is applied in a single dose to the skin of an experimental animal; untreated skin areas of the test animal serve as the control. • The degree of irritation/corrosion is read and scored at specified intervals and is further described in order to provide a complete evaluation of the effects. • The duration of the study should be sufficient to evaluate the reversibility or irreversibility of the effects observed. • Animals showing continuing signs of severe distress and/or pain at any stage of the test should be humanely killed, and the test chemical assessed accordingly. • Criteria for making the decision to humanely kill moribund and severely suffering animals are the subject of a separate Guidance Document.
  • 5. PREPARATION FOR THE IN VIVO TEST SELECTION OF ANIMAL SPECIES- • The albino rabbit is the preferable laboratory animal and healthy young adult rabbits are used. • A rationale for using other species should be provided. PREPARATION OF THE ANIMALS- • Approximately 24 hours before the test, fur should be removed by closely clipping the dorsal area of the trunk of the animals. • Care should be taken to avoid abrading the skin, and only animals with healthy, intact skin should be used. • Some strains of rabbit have dense patches of hair that are more prominent at certain times of the year. Such areas of dense hair growth should not be used as test sites.
  • 6. HOUSING AND FEEDING CONDITIONS - • Animals should be individually housed. • Rabbit at least 12 weeks old and body weight 1.5 kg-3.0 kg. • The temperature should be 200C (± 30C) for rabbits. • Relative humidity should be at least 30% and preferably not exceed 70%, other than during room cleaning; the aim should be 50-60%. • Lighting should be 12 hours light, 12 hours dark. • For feeding, conventional laboratory diets may be used with an unrestricted supply of drinking water.
  • 7. TEST PROCEDURE APPLICATION OF THE TEST CHEMICAL • The test chemical should be applied to a dorsal/flank region (approximately 6 cm2) of skin and covered with a gauze patch, which is held in place with non- irritating tape. • In cases in which direct application is not possible (e.g., liquids or some pastes), the test chemical should first be applied to the gauze patch, which is then applied to the skin. • The patch should be loosely held in contact with the skin by means of a suitable semi- occlusive dressing for the duration of the exposure period. • If the test chemical is applied to the patch, it should be attached to the skin in such a manner that there is good contact and uniform distribution of the test chemical on the skin.
  • 8. • Access by the animal to the patch and ingestion or inhalation of the test chemical should be prevented. • Liquid test chemicals are generally used undiluted. • When testing solids (which may be pulverised, if considered necessary), the test chemical should be moistened with the smallest amount of water (or, where necessary, of another suitable vehicle) sufficient to ensure good skin contact. • When vehicles other than water are used, the potential influence of the vehicle on irritation of the skin by the test chemical should be minimal, if any. • At the end of the exposure period, which is normally 4 hours, residual test chemical should be removed, where practicable, using water or an appropriate solvent without altering the existing response or the integrity of the epidermis. DOSE LEVEL • A dose of 0.5 mL of liquid or 0.5 g of solid or paste is applied to the test site.
  • 9.
  • 10. INITIAL TEST (USING ONE ANIMAL)  When a test chemical has been judged to be corrosive, irritant or non- classified on the basis of a weight of evidence analyses or of previous in vitro testing, further in vivo testing is normally not necessary.  However, in the cases where additional data are felt warranted, the in vivo test is performed initially using one animal and applying the following approach.  Up to three test patches are applied sequentially to the animal.  The first patch is removed after three minutes.  If no serious skin reaction is observed, a second patch is applied at a different site and removed after one hour.
  • 11.  If the observations at this stage indicate that exposure can humanely be allowed to extend to four hours, a third patch is applied and removed after four hours, and the response is graded.  If a corrosive effect is observed after any of the three sequential exposures, the test is immediately terminated.  If a corrosive effect is not observed after the last patch is removed, the animal is observed for 14 days, unless corrosion develops at an earlier time point.  In those cases, in which the test chemical is not expected to produce corrosion but may be irritating, a single patch should be applied to one animal for four hours.
  • 12. CONFIRMATORY TEST (WITH ADDITIONAL ANIMALS)  If a corrosive effect is not observed in the initial test, the irritant or negative response should be confirmed using up to two additional animals, each with one patch, for an exposure period of four hours.  If an irritant effect is observed in the initial test, the confirmatory test may be conducted in a sequential manner, or by exposing two additional animals simultaneously.  In the exceptional case, in which the initial test is not conducted, two or three animals may be treated with a single patch, which is removed after four hours.  When two animals are used, if both exhibit the same response, no further testing is needed. Otherwise, the third animal is also tested.  Equivocal responses may need to be evaluated using additional animals.
  • 13. OBSERVATION PERIOD  The duration of the observation period should be sufficient to evaluate fully the reversibility of the effects observed.  The experiment should be terminated at any time that the animal shows continuing signs of severe pain or distress.  To determine the reversibility of effects, the animals should be observed up to 14 days after removal of the patches.  If reversibility is seen before 14 days, the experiment should be terminated at that time.
  • 14. CLINICAL OBSERVATIONS AND GRADING OF SKIN REACTIONS  All animals should be examined for signs of erythema and oedema, and the responses scored at 60 minutes, and then at 24, 48 and 72 hours after patch removal.  For the initial test in one animal, the test site is also examined immediately after the patch has been removed.  Dermal reactions are graded and recorded according to the grades in the Table below.  If there is damage to skin which cannot be identified as irritation or corrosion at 72 hours, observations may be needed until day 14 to determine the reversibility of the effects.  In addition to the observation of irritation, all local toxic effects, such as defatting of the skin, and any systemic adverse effects (e.g., effects on clinical signs of toxicity and body weight), should be fully described and recorded.  Histopathological examination should be considered to clarify equivocal responses.
  • 15.
  • 16.